Earnings Feed
Start Free
Home/Insiders/Weinberg Uri
WU
SEC Insider//CIK 0001811030

Weinberg Uri

CIK 00018110301 companyWAYNE, PA
SEC Profile

Transactions

50

Companies

1

Filings

9

CIK

0001811030

Recent Transactions

50 trades
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-03-04$18.19/sh+54,975→ 221,218 total
  • Award
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2025-03-04$18.19/sh+81,499→ 81,499 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-03-03$18.92/sh−268→ 166,243 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.31/sh−311→ 166,511 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.78/sh−4,326→ 166,822 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.31/sh−311→ 166,511 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.78/sh−4,326→ 166,822 total
  • Award
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2024-02-27$16.30/sh+125,078→ 125,078 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-02-27$16.30/sh+81,799→ 171,148 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-06-30$35.28/sh+305→ 89,349 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+28,830→ 85,108 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+3,936→ 89,044 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-02-28$76.97/sh+21,607→ 21,607 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-02-28+12,992→ 56,278 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$120.00/sh−1,201→ 43,286 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$120.00/sh−1,946→ 47,104 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-01-05−1,946→ 1,946 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$47.04/sh+1,946→ 49,050 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$108.00/sh−2,617→ 44,487 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$120.00/sh−2,379→ 47,104 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-07-05$59.08/sh+281→ 49,483 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+4,961→ 4,961 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+30,422→ 30,422 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03+17,371→ 49,186 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-01-06$63.82/sh+35→ 31,815 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-07-06$137.12/sh+113→ 31,780 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-05-10−3,846→ 3,845 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-05-10$47.56/sh+3,846→ 37,317 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-05-10$189.65/sh−1,804→ 31,667 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-05-10$189.65/sh−3,846→ 33,471 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-03-23$140.00/sh−3,892→ 36,306 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-03-23$47.04/sh+3,892→ 40,198 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-03-23−3,892→ 3,892 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-03-23$140.00/sh−2,835→ 33,471 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-02+8,709→ 36,306 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-03-02+16,003→ 16,003 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-02-22$7.15/sh+6,500→ 34,097 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-02-22−6,500→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-02-22$175.50/sh−6,500→ 27,597 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-09-25−8,750→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-09-25$103.35/sh−8,750→ 27,597 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-09-25$103.35/sh−6,500→ 27,597 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-09-25$11.46/sh+8,750→ 36,347 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-09-25−6,500→ 6,500 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-09-25$7.15/sh+6,500→ 34,097 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-09-01+3,779→ 3,779 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Share Units

    2020-09-01+1,968→ 27,597 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-07$50.41/sh+325→ 30,357 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-05-08$63.84/sh+1,402→ 25,629 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Share Units

    2020-05-08−1,402→ 2,803 total

Companies

1

Recent Filings

9

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087

View on SEC.gov